⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARQT News
Arcutis Biotherapeutics, Inc. Common Stock
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
globenewswire.com
ARQT
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
prnewswire.com
ALNY
ARQT
IONS
JAZZ
JNJ
MRK
PFE
AKBA
ARDX
BMY
BIIB
GILD
INSM
NVS
AGIO
BBIO
CRNX
GERN
KAVL
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ARQT
Form 8-K
sec.gov
ARQT
Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
ARQT
Form 8-K
sec.gov
ARQT
Arcutis Expands Board of Directors with Appointment of Chris Peetz
globenewswire.com
ARQT
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
globenewswire.com
ARQT
Attovia Therapeutics Appoints John W. Smither to Board of Directors
globenewswire.com
MBX
ARQT
NAMS
GNLX
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
globenewswire.com
ARQT